aka LY3437943 · Triple G
Open any panel for the full data
Retatrutide is a novel triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Developed by Eli Lilly, it has demonstrated unprecedented weight loss results in Phase 2 trials, with participants losing up to 24% of body weight. The triple mechanism may provide superior metabolic benefits compared to dual agonists like tirzepatide.
Third-party creator videos and discussion, surfaced for research context. Amino Axiom does not endorse creator claims.
Retatrutide and 5-Amino-1-MQ Combined - Dr Trevor Bachmeyer
MOTS-C, Retatrutide and Methylene Blue (Solving Fatigue Permanently) - Dr Trevor Bachmeyer
MOTS-C & Retatrutide at the same time (this one is awesome) Comment “HELP” for research Let me paint you a picture of what MOTS-C and Retatr
Retatrutide and MOTS-C combined This is insane… Comment “LIFE” for research (the full research playbook) Nature Aging showed MOTS-C reverses
your GLP-1 results will stall without this one thing 👇 resistance training 💪 not walking not yoga not “staying active” lifting heavy thing